92602 ⎘
Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
RESIN COMPOSITION, DIAMINE COMPOUND, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE
#2LIPOXYGENASE INHIBITORS
#3Polymeric amine synergist
#4Polymeric amine synergist compositions
#5PHENYL BENZYL ETHER DERIVATIVE AND PREPARATION METHOD AND APPLICATION THEREOF
#6Process for the Synthesis of Arformoterol
#72,4,5-TRIAMINOPHENOLS AND RELATED COMPOUNDS
#82,4,5-TRIAMINOPHENOLS AND RELATED COMPOUNDS
#9PROCESSES FOR PREPARING SUBSTANTIALLY PURE ARFORMOTEROL AND ITS INTERMEDIATES
#10Process for the synthesis of arformoterol
#11PAI-1 inhibitor
#12Management of Ophthalmologic Disorders, Including Macular Degeneration
#13(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
#14PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS
#15Diamine and polyamic acid derived therefrom for liquid crystal orientation applications
#16Carboxilic acid derivatives
#17Management of Ophthalmologic Disorders, Including Macular Degeneration
#18Management of Ophthalmologic Disorders, Including Macular Degeneration
#19(R)-Chiral Halogenated Substituted Fused Heterocyclic Amino Compounds Useful for Inhibiting Cholesterol Ester Transfer Protein Activity
#20Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
#21Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
#22(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
#23Substituted p-diaminobenzene derivatives
#24Management of ophthalmologic disorders, including macular degeneration
#25Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
#26Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
#27(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity